Remote Irritable Bowel Syndrome (IBS) Monitoring Global Market Report 2025

Description

Remote irritable bowel syndrome (IBS) monitoring refers to a digital health system that facilitates continuous observation and management of IBS symptoms. It captures real-time patient data, evaluates patterns, and generates actionable insights to support proactive healthcare decisions. This monitoring approach enhances patient engagement, enables timely interventions, and contributes to better symptom management and improved quality of life.

The main components of remote irritable bowel syndrome (IBS) monitoring include devices, software, and services. Devices comprise hardware tools and wearable technologies that help track, record, and monitor patients' digestive health and IBS symptoms. It is used across several applications such as diagnosis, symptom tracking, treatment management, patient education, and others, and serves various end users, including hospitals and clinics, homecare settings, research institutions, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The remote irritable bowel syndrome (IBS) monitoring market research report is one of a series of new reports from The Business Research Company that provides remote irritable bowel syndrome (IBS) monitoring market statistics, including remote irritable bowel syndrome (IBS) monitoring industry global market size, regional shares, competitors with a remote irritable bowel syndrome (IBS) monitoring market share, detailed remote irritable bowel syndrome (IBS) monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the remote irritable bowel syndrome (IBS) monitoring industry. The remote irritable bowel syndrome (IBS) monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The remote irritable bowel syndrome (IBS) monitoring market size has grown rapidly in recent years. It will grow from $1.21 billion in 2024 to $1.40 billion in 2025 at a compound annual growth rate (CAGR) of 16.2%. The growth during the historic period can be attributed to the rising prevalence of gastrointestinal disorders, increasing awareness of IBS and digestive health, growing demand for non-invasive monitoring solutions, wider adoption of digital health technologies, increasing use of smartphones and wearable devices, higher healthcare spending, and a stronger focus on patient-centered care.

The remote irritable bowel syndrome (IBS) monitoring market size is expected to see rapid growth in the next few years. It will grow to $2.53 billion in 2029 at a compound annual growth rate (CAGR) of 15.8%. The growth during the forecast period can be attributed to the increasing use of connected devices for gastrointestinal monitoring, greater integration with telehealth and virtual consultations, rising demand for personalized treatment approaches, and the expansion of remote patient monitoring programs. Key trends in the forecast period include technological advancements in biosensors and wearable devices, innovations in AI-based symptom tracking, progress in cloud-based health platforms, research and development in gut microbiome analysis, integration with digital therapeutics and mobile applications, and the use of data analytics for predictive and real-time monitoring.

The rising prevalence of gastrointestinal disorders is expected to drive the growth of the remote irritable bowel syndrome (IBS) monitoring market in the coming years. Gastrointestinal disorders are conditions that disrupt the normal functioning of the digestive system, affecting digestion and bowel regulation. The increase in such disorders is primarily linked to unhealthy dietary habits that negatively impact gut health, causing inflammation, bloating, and other digestive discomforts. Remote irritable bowel syndrome (IBS) monitoring helps reduce symptom severity and slow disease progression by enabling early detection of triggers and continuous management, resulting in improved patient outcomes and enhanced quality of life. For example, in February 2025, Crohn's & Colitis Australia, a national organization based in Australia, reported that the projected prevalence of inflammatory bowel disease (IBD) in the country is expected to rise from 20,511,881 cases in 2023 to 23,067,771 cases by 2030. Therefore, the growing incidence of gastrointestinal disorders is contributing to the expansion of the remote irritable bowel syndrome (IBS) monitoring market.

Leading companies in the remote irritable bowel syndrome (IBS) monitoring market are focusing on introducing white-label and co-branded service models to strengthen their capabilities and improve patient accessibility. These models enable healthcare providers to deliver ready-to-use digital health solutions under their own brand, combining trusted clinical identity with proven technology to achieve faster implementation, reduced costs, and an improved patient experience. For instance, in May 2024, Salvo Health, a US-based digital gastrointestinal care provider, introduced its first remote patient monitoring (RPM) solution for managing chronic gastrointestinal (GI) conditions. The program offers digital care options for conditions such as IBS, GERD, dyspepsia, celiac disease, and SIBO, integrating remote monitoring with traditional in-person care. Through its white-label and co-branded model, Salvo provides GI practitioners with digital tools, clinical staff, and home monitoring devices to track heart rate variability (HRV) and connect it with patient diet, behavior, and symptoms, enhancing chronic care outcomes and operational efficiency.

In March 2024, Mahana Therapeutics, a US-based company specializing in digital chronic condition management programs, acquired HiDoc Technologies GmbH for an undisclosed amount. This acquisition aims to expand Mahana Therapeutics' global footprint in digital chronic disease management, strengthen its digestive health portfolio, and improve patient outcomes through digital cognitive behavioral therapy (CBT) programs while accelerating commercialization efforts in the US and Europe. HiDoc Technologies GmbH is a Germany-based company offering remote monitoring for irritable bowel syndrome (IBS) through its digital health application, Cara Care.

Major players in the remote irritable bowel syndrome (IBS) monitoring market are Indegene, Vivante Health, Thryve Health, Heali AI Corp., Mahana Therapeutics Inc., metaMe Health Inc., Seed Health, Ayble Health, Oshi health, Salvo Health Inc., modifyhealth Inc., Food marble, nerva health, MyGiHealth, Sun Genomics, Dietahealth, Dige Health, Nori health, Sequenex, and Bowelle.

North America was the largest region in the remote irritable bowel syndrome (IBS) monitoring market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in remote irritable bowel syndrome (IBS) monitoring report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the remote irritable bowel syndrome (IBS) monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The remote irritable bowel syndrome (IBS) monitoring market consists of revenues earned by entities by providing services such as teleconsultations with gastroenterologists, dietary and lifestyle management guidance, digital health coaching, and patient data analytics. The market value includes the value of related goods sold by the service provider or included within the service offering. The remote irritable bowel syndrome (IBS) monitoring market also includes sales of wearable gut activity monitors, smart sensors, mobile monitoring devices, and connected health tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Remote Irritable Bowel Syndrome (IBS) Monitoring Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on remote irritable bowel syndrome (ibs) monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for remote irritable bowel syndrome (ibs) monitoring ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The remote irritable bowel syndrome (ibs) monitoring market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Component: Devices; Software; Services
2) By Application: Diagnosis; Symptom Tracking; Treatment Management; Patient Education; Other Applications
3) By End-User: Hospitals And Clinics; Homecare Settings; Research Institutes; Other End-Users
Subsegments:
1) By Devices: Wearable Monitoring Devices; Non-Wearable Monitoring Devices; Portable Monitoring Devices; Implantable Monitoring Devices
2) By Software: Data Analytics Software; Mobile Health Applications; Remote Monitoring Platforms; Cloud-Based Software Solutions
3) By Services: Teleconsultation Services; Data Management Services; Technical Support Services; Training And Education Services
Companies Mentioned: Indegene; Vivante Health; Thryve Health; Heali AI Corp.; Mahana Therapeutics Inc.; metaMe Health Inc.; Seed Health; Ayble Health; Oshi health; Salvo Health Inc.; modifyhealth Inc.; Food marble; nerva health; MyGiHealth; Sun Genomics; Dietahealth; Dige Health; Nori health; Sequenex; Bowelle.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r39346

1. Executive Summary

2. Remote Irritable Bowel Syndrome (IBS) Monitoring Market Characteristics

3. Remote Irritable Bowel Syndrome (IBS) Monitoring Market Trends And Strategies

4. Remote Irritable Bowel Syndrome (IBS) Monitoring Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Remote Irritable Bowel Syndrome (IBS) Monitoring Growth Analysis And Strategic Analysis Framework

5.1. Global Remote Irritable Bowel Syndrome (IBS) Monitoring PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Remote Irritable Bowel Syndrome (IBS) Monitoring Market Growth Rate Analysis
5.4. Global Remote Irritable Bowel Syndrome (IBS) Monitoring Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Remote Irritable Bowel Syndrome (IBS) Monitoring Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Remote Irritable Bowel Syndrome (IBS) Monitoring Total Addressable Market (TAM)

6. Remote Irritable Bowel Syndrome (IBS) Monitoring Market Segmentation

6.1. Global Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Devices
Software
Services
6.2. Global Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnosis
Symptom Tracking
Treatment Management
Patient Education
Other Applications
6.3. Global Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Homecare Settings
Research Institutes
Other End-Users
6.4. Global Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Wearable Monitoring Devices
Non-Wearable Monitoring Devices
Portable Monitoring Devices
Implantable Monitoring Devices
6.5. Global Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Data Analytics Software
Mobile Health Applications
Remote Monitoring Platforms
Cloud-Based Software Solutions
6.6. Global Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Teleconsultation Services
Data Management Services
Technical Support Services
Training And Education Services

7. Remote Irritable Bowel Syndrome (IBS) Monitoring Market Regional And Country Analysis

7.1. Global Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Remote Irritable Bowel Syndrome (IBS) Monitoring Market

8.1. Asia-Pacific Remote Irritable Bowel Syndrome (IBS) Monitoring Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Remote Irritable Bowel Syndrome (IBS) Monitoring Market

9.1. China Remote Irritable Bowel Syndrome (IBS) Monitoring Market Overview
9.2. China Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Remote Irritable Bowel Syndrome (IBS) Monitoring Market

10.1. India Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Remote Irritable Bowel Syndrome (IBS) Monitoring Market

11.1. Japan Remote Irritable Bowel Syndrome (IBS) Monitoring Market Overview
11.2. Japan Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Remote Irritable Bowel Syndrome (IBS) Monitoring Market

12.1. Australia Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Remote Irritable Bowel Syndrome (IBS) Monitoring Market

13.1. Indonesia Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Remote Irritable Bowel Syndrome (IBS) Monitoring Market

14.1. South Korea Remote Irritable Bowel Syndrome (IBS) Monitoring Market Overview
14.2. South Korea Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Remote Irritable Bowel Syndrome (IBS) Monitoring Market

15.1. Western Europe Remote Irritable Bowel Syndrome (IBS) Monitoring Market Overview
15.2. Western Europe Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Remote Irritable Bowel Syndrome (IBS) Monitoring Market

16.1. UK Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Remote Irritable Bowel Syndrome (IBS) Monitoring Market

17.1. Germany Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Remote Irritable Bowel Syndrome (IBS) Monitoring Market

18.1. France Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Remote Irritable Bowel Syndrome (IBS) Monitoring Market

19.1. Italy Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Remote Irritable Bowel Syndrome (IBS) Monitoring Market

20.1. Spain Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Remote Irritable Bowel Syndrome (IBS) Monitoring Market

21.1. Eastern Europe Remote Irritable Bowel Syndrome (IBS) Monitoring Market Overview
21.2. Eastern Europe Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Remote Irritable Bowel Syndrome (IBS) Monitoring Market

22.1. Russia Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Remote Irritable Bowel Syndrome (IBS) Monitoring Market

23.1. North America Remote Irritable Bowel Syndrome (IBS) Monitoring Market Overview
23.2. North America Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Remote Irritable Bowel Syndrome (IBS) Monitoring Market

24.1. USA Remote Irritable Bowel Syndrome (IBS) Monitoring Market Overview
24.2. USA Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Remote Irritable Bowel Syndrome (IBS) Monitoring Market

25.1. Canada Remote Irritable Bowel Syndrome (IBS) Monitoring Market Overview
25.2. Canada Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Remote Irritable Bowel Syndrome (IBS) Monitoring Market

26.1. South America Remote Irritable Bowel Syndrome (IBS) Monitoring Market Overview
26.2. South America Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Remote Irritable Bowel Syndrome (IBS) Monitoring Market

27.1. Brazil Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Remote Irritable Bowel Syndrome (IBS) Monitoring Market

28.1. Middle East Remote Irritable Bowel Syndrome (IBS) Monitoring Market Overview
28.2. Middle East Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Remote Irritable Bowel Syndrome (IBS) Monitoring Market

29.1. Africa Remote Irritable Bowel Syndrome (IBS) Monitoring Market Overview
29.2. Africa Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Remote Irritable Bowel Syndrome (IBS) Monitoring Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Remote Irritable Bowel Syndrome (IBS) Monitoring Market Competitive Landscape And Company Profiles

30.1. Remote Irritable Bowel Syndrome (IBS) Monitoring Market Competitive Landscape
30.2. Remote Irritable Bowel Syndrome (IBS) Monitoring Market Company Profiles
- 30.2.1. Indegene Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Vivante Health Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Thryve Health Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Heali AI Corp. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Mahana Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Remote Irritable Bowel Syndrome (IBS) Monitoring Market Other Major And Innovative Companies

31.1. metaMe Health Inc.
31.2. Seed Health
31.3. Ayble Health
31.4. Oshi health
31.5. Salvo Health Inc.
31.6. modifyhealth Inc.
31.7. Food marble
31.8. nerva health
31.9. MyGiHealth
31.10. Sun Genomics
31.11. Dietahealth
31.12. Dige Health
31.13. Nori health
31.14. Sequenex
31.15. Bowelle

32. Global Remote Irritable Bowel Syndrome (IBS) Monitoring Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Remote Irritable Bowel Syndrome (IBS) Monitoring Market

34. Recent Developments In The Remote Irritable Bowel Syndrome (IBS) Monitoring Market

35. Remote Irritable Bowel Syndrome (IBS) Monitoring Market High Potential Countries, Segments and Strategies

35.1 Remote Irritable Bowel Syndrome (IBS) Monitoring Market In 2029 - Countries Offering Most New Opportunities
35.2 Remote Irritable Bowel Syndrome (IBS) Monitoring Market In 2029 - Segments Offering Most New Opportunities
35.3 Remote Irritable Bowel Syndrome (IBS) Monitoring Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer